The story of Sildenafil presents a complex case for investors in the medicinal sector. While initially a blockbuster success, creating vast sums, the patent end and the subsequent arrival of off-brand competitors have https://pharma823806.blogars.com/40216695/viagra-and-the-pharmaceutical-industry-a-hazardous-play